CMS Open Payments Data Analysis: Spend by Drug
Comparison from 2021 – 2023
Get insights into the fluctuations and trends in spending by drug, based on data reported to the CMS by life sciences companies from 2021 to 2023.
The comprehensive analysis and comparison guide is designed to help you understand spending patterns across top life sciences companies, identify potential compliance risks, and address them effectively to ensure legal adherence.
- Discover the key trends and shifts in expenditures over the last three years
- Identify potential compliance red flags, including large fluctuations in spend
- Gain actionable insights to streamline compliance audits and reporting
- Ensure expenditures align with legal frameworks to prevent potential risks